An official website of the United States government

January 13, 2022

3rd COVAX/GAVI COVID 19 Vaccine Delivery to Chad

Chargé d’Affaires of the U.S Embassy a.i. Ellen B. Thorburn on left side handing over vaccine at the ceremony of the donation.

On December 3rd, the U.S. Embassy in Chad, in collaboration with the Ministry of Public Health and the World Health Organization, received a 3rd shipment of COVID-19 vaccine for Chad. This shipment of 170,300 Johnson & Johnson vaccines is part of a global U.S. effort to fight the COVID-19 pandemic and the U.S. commitment to deliver doses to Africa. That’s 250 million doses delivered worldwide – 50 million doses to 43 African countries – and more than 400,000 vaccines for Chadians.

The United States and international partners are working to distribute millions of doses of lifesaving COVID-19 vaccines to countries around the world. COVAX, an international partnership dedicated to equitable global access to vaccines, aims to distribute 2 billion doses of vaccine against COVID-­19 by the end of 2021. COVAX is coordinated by Gavi, the Coalition for Epidemic Preparedness Innovations, UNICEF and the World Health Organization.

The United States contributed $2 billion to COVAX and has pledged an additional $2 billion through 2022. U.S. investments support the COVAX AMC to procure and deliver vaccines to low- and middle-income countries.

Our other bilateral donations via COVAX, to Chad as of January 2022 are:

  1. 117,000 Pfizer vaccine doses on October 2, 2021
  2. 115,830 Pfizer vaccine doses on October 30, 2021
  3. 170,000 Johnson & Johnson vaccine doses on November 27, 2021
  4. 149,760 Pfizer vaccine doses on January 7, 2022